Evidence map›Paper›PMID 28049460›Full record

ArticleBMC complementary and alternative medicine2017

Bitter melon protects against ER stress in LS174T colonic epithelial cells.

Dale A Kunde, Wai Chin Chong, Prathiba V Nerurkar, Kiran D K Ahuja, Jeremy Just, Jason A Smith, Nuri Guven, Rajaraman D Eri

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. An update on extra-oral bitter taste receptors.Journal of translational medicine · 2021
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Dale A KundeSchool of Health Sciences, University of Tasmania, Launceston, 7250, TAS, Australia.
Wai Chin ChongSchool of Health Sciences, University of Tasmania, Launceston, 7250, TAS, Australia.
Prathiba V NerurkarDepartment of Molecular Biosciences & Bioengineering, University of Hawaii, Honolulu, HI, USA.
Kiran D K AhujaSchool of Health Sciences, University of Tasmania, Launceston, 7250, TAS, Australia.
Jeremy JustSchool of Physical Sciences, University of Tasmania, Hobart, 7000, TAS, Australia.
Jason A SmithSchool of Physical Sciences, University of Tasmania, Hobart, 7000, TAS, Australia.
Nuri GuvenSchool of Medicine, University of Tasmania, Hobart, 7000, TAS, Australia.
Rajaraman D EriSchool of Health Sciences, University of Tasmania, Launceston, 7250, TAS, Australia. rderi@utas.edu.au.
University of Tasmania · AUUniversity of Hawaii System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBitter Melon (BM) has been used as a functional food in traditional Chinese and Indian medicine for many generations and has gained a great deal of attention due to its apparent benefits in moderating some of the pathogenic processes in a variety of inflammatory conditions. BM extract (BME) has been shown to possess strong anti-oxidant properties. In addition, it can ameliorate oxidative stress and potentially ER stress. There is increasing evidence that oxidative and ER stress are major contributors for intestinal secretory cell dysfunction which leads to local inflammation and disease pathogenesis that are hallmarks of inflammatory bowel diseases (IBD). Hence, the search for potential therapeutics against ER stress and oxidative stress in intestinal epithelial secretory cells may provide valuable resources for the management of IBD. The aim of the present study was to investigate the effects of BME in ameliorating ER stress in colonic epithelial cells.

methodsHuman colonic adenocarcinoma LS174T cells were used for the assessment of BME effects on colonic epithelial cells in vitro. Cell viability was assessed using trypan blue exclusion and the effect of BME in ameliorating tunicamycin (TM)-induced ER stress was determined by analysing the mRNA expression of the common ER stress markers; ATF6, XBP1, GRP78, CHOP and PERK by quantitative RT-PCR and GRP78 and CHOP by western blot.

resultsIn the absence of ER stress, BME exhibited no cell toxicity up to 2.0% w/v and no significant effect on the basal mRNA expression of ER stress markers in LS174T cells. In contrast, pre-treatment of LS174T cells with BME followed by induction of ER stress resulted in a significant decrease in mRNA expression of ATF6, XBP1, GRP78, CHOP and PERK and protein expression of GRP78 and CHOP. Co-treatment during induction of ER stress and post- treatment following induction of ER Stress in LS174T cells resulted in a lower but still significant reduction in mRNA expression levels of most ER stress markers.

conclusionsThis is one of the first studies demonstrating the efficacy of BME in reducing expression of ER stress markers in colonic epithelial cells suggesting the potential of BME as a dietary intervention in ameliorating ER stress and oxidation in IBD. Interestingly, while the most significant effect was seen with pre-treatment of cells with BME there was a reduced but still significant effect when co-treated or even post-treated. This suggests that BME may even be effective in modulating ER stress in the face of an existing cell stress environment.

Indexed as

Cell Line, TumorColonEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressEpithelial CellsHeat-Shock ProteinsHumansInflammatory Bowel DiseasesMomordica charantiaOxidative StressPlant ExtractsProtective AgentsTranscription Factor CHOPTunicamycinX-Box Binding Protein 1Endoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHSPA5 protein, humanPlant ExtractsProtective AgentsTranscription Factor CHOPTunicamycinX-Box Binding Protein 1XBP1 protein, humanBitter melonEndoplasmic reticulum stressInflammatory bowel diseaseIntestinal secretory cellsOxidative stressUnfolded protein responses

Identifiers

PMID28049460
PMCPMC5210302
OpenAlexW2563015397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.